`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`MEDYTOX, INC.,
`Appellant
`
`
`
`v.
`
`
`
`
`GALDERMA S.A., GALDERMA LABORATORIES
`INC., GALDERMA LABORATORIES, L.P.,
`GALDERMA RESEARCH AND DEVELOPMENT,
`S.N.C., SHDS, INC., GALDERMA HOLDINGS S.A.,
`Appellees
`
`
`
`KATHERINE K. VIDAL, UNDER SECRETARY OF
`COMMERCE FOR INTELLECTUAL PROPERTY
`AND DIRECTOR OF THE UNITED STATES
`PATENT AND TRADEMARK OFFICE,
`Intervenor
`______________________
`2022-1165
`______________________
`Appeal from the United States Patent and Trademark
`Office, Patent Trial and Appeal Board in No. PGR2019-
`00062.
`
`______________________
`
`MANDATE
`______________________
`In accordance with the judgment of this Court, entered
`June 27, 2023, and pursuant to Rule 41 of the Federal
`
`
`
`Case: 22-1165 Document: 63 Page: 2 Filed: 08/18/2023
`
`Rules of Appellate Procedure, the formal mandate is
`hereby issued.
`
`
`
`
`
`
`
`August 18, 2023
`Date
`
`
`FOR THE COURT
`
`/s/ Jarrett B. Perlow
`Jarrett B. Perlow
`Clerk of Court
`
`
`
`
`
`